New app aims to boost quality of life for leukemia patients

NCT ID NCT06472128

First seen Nov 11, 2025 · Last updated May 14, 2026 · Updated 23 times

Summary

This study tests a digital app called DREAMLAND to see if it can improve quality of life and emotional well-being for adults with acute myeloid leukemia (AML) who are receiving intensive chemotherapy. About 200 participants will use either DREAMLAND or a standard wellness app. The main goal is to measure changes in quality of life 20 days after starting treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIGH-RISK ACUTE MYELOID LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Duke University

    NOT_YET_RECRUITING

    Durham, North Carolina, 27710, United States

    Contact Email: •••••@•••••

  • Fred Hutchinson Cancer Research Center (FHCRC)

    NOT_YET_RECRUITING

    Seattle, Washington, 98109, United States

    Contact Email: •••••@•••••

  • Massachusetts General Hospital (MGH)

    RECRUITING

    Boston, Massachusetts, 02114, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.